Trump 2019: Three Things To Expect in Health Care
Client Alert | 1 min read | 12.12.18
As part of our Trump 2019: What To Expect series, Traci Vitek, senior policy director with the firm, and Jerrica Mathis, director in Crowell & Moring’s Government Affairs Group, sit down to discuss what we can expect Congress and the White House to focus on in 2019 regarding health care.
Discussed in this 24-minute podcast:
- Health care plans and how they are marketed.
- Drug pricing proposals.
- Congressional oversight.
Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes
Insights
Client Alert | 4 min read | 02.20.26
SCOTUS Holds IEEPA Tariffs Unlawful
On February 20, 2026, the Supreme Court issued a pivotal ruling in Trump v. V.O.S. Selections, negating the President’s ability to impose tariffs under IEEPA. The case stemmed from President Trump’s invocation of IEEPA to levy tariffs on imports from Canada, Mexico, China, and other countries, citing national emergencies. Challengers argued—and the Court agreed—that IEEPA does not delegate tariff authority to the President. The power to tariff is vested in Congress by the Constitution and cannot be delegated to the President absent express authority from Congress.
Client Alert | 7 min read | 02.20.26
Section 5949 Proposed Rule Puts the FAR Council's Chips on the Table
Client Alert | 5 min read | 02.20.26
Trump Administration Pursues MFN Pricing for Prescription Drugs
Client Alert | 4 min read | 02.19.26
Proposed NY Legislation May Mean Potential Criminal Charges for Unlicensed Crypto Firms
